Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
236 studies found for:    cgms, type 2
Show Display Options
Rank Status Study
1 Completed
Has Results
Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Device: Continuous Glucose Monitoring (CGM)
2 Unknown  Continuous Glucose Monitoring in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Device: Continuous Glucose Monitor;   Device: Glucometer
3 Completed Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring
Condition: Type 2 Diabetes
Interventions: Other: SMBG to guide clinical decisions;   Other: SMBG and CGM
4 Completed Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study
Condition: Type 2 Diabetes Mellitus
Intervention: Device: CGMS with an insulin pump using rapid acting insulin
5 Recruiting An Exploratory Study to Evaluate the Effects of Trelagliptin and Alogliptin by CGM on Glucose Variability for One Week With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Trelagliptin;   Drug: Alogliptin
6 Completed Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin
Condition: Type 2 Diabetes Mellitus
Interventions: Other: Remote Blood Glucose Monitoring;   Other: Continuous Glucose Monitoring;   Other: SMBG;   Other: SMBG With Knowledge
7 Recruiting A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM
Condition: Haemodialyzed, Type 2 Diabetes
Interventions: Drug: Vildagliptin (Galvus);   Drug: Insulin
8 Completed Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
Condition: Type 2 Diabetes Mellitus
9 Completed Glucose Response, Excursions And Treatment (GREAT) Study
Condition: Type 2 Diabetes
Interventions: Drug: DPPIV inhibitor -;   Device: Continuous glucose monitoring system.
10 Suspended Comparing Internet Blood Glucose Monitoring System and Continuous Glucose Monitoring System
Condition: Type 2 Diabetes Mellitus
Interventions: Other: Remote Blood Glucose Monitoring;   Other: Continuous Glucose Monitoring
11 Completed Relationship Between HbA1c, Fasting Plasma Glucose, Post-prandial Glucose and Other Measures of Glycemic Control
Condition: Diabetes Mellitus, Type 2
Intervention: Device: 6-day Continuous Glucose Monitoring System
12 Completed
Has Results
Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Vildagliptin;   Drug: Sitagliptin
13 Completed Aerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Treatment;   Exercise
Interventions: Behavioral: Acute aerobic exercise;   Behavioral: Acute aerobic-resistance exercise
14 Recruiting SMBG Protocols Predicting Glucose Levels in Senior Diabetics With CAD
Conditions: Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions: Behavioral: SMBG;   Other: CGMS
15 Completed CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
Condition: Type 2 Diabetes
16 Recruiting the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin
Condition: Type 2 Diabetes
Interventions: Drug: premix insulin;   Drug: metformin;   Drug: Acarbose
17 Recruiting Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Teneligliptin;   Drug: Sitagliptin
18 Completed
Has Results
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
19 Completed Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Glibenclamide
20 Unknown  Healthy Moms, Healthy Babies
Conditions: Type 2 Diabetes Mellitus;   Gestational Diabetes
Interventions: Device: Continuous Glucose Monitoring;   Device: Glucose Meter

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years